Clonova Spółka z Ograniczoną Odpowiedzialnością (KRS 0000469830, NIP 9721244955) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. CLONOVA operates in: Manufacture of medical and dental instruments and supplies (PKD 32.50.Z). Industry: Other manufacturing. The company has been listed in the National Court Register since July 12, 2013. CLONOVA's most recently reported net revenue was 235.0 K PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Clonova
Identity
- Name
- Clonova Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- July 12, 2013
- Registry status as of
- November 21, 2025
- Latest entry
- April 30, 2025
- Founding act
- 10.07.2013 R.
Articles of association history (3)
- July 10, 2013: 10.07.2013 R.
- August 9, 2016: 09.08.2016R., REPERTORIUM A NR 2560/2016, NOTARIUSZ AGNIESZKA MROZEWICZ-KUCHLEWSKA, KANCELARIA NOTARIALNA W POZNANIU: ZMIENIONO §3 UMOWY SPÓŁKI ORAZ PRZYJĘTO TEKST JEDNOLITY UMOWY SPÓŁKI.
- September 28, 2018: AKT NOTARIALNY Z DNIA 28.09.2018 R., REP. A NR 5549/2018, NOTARIUSZ PAWEŁ ŻMUDA- TRZEBIATOWSKI, KANCELARIA NOTARIALNA, UL. KAZIMIERZA PUŁASKIEGO 28/3, 60-607 POZNAŃ, ZMIANIE ULEGŁ § 4 UMOWY SPÓŁKI - WYKREŚLONO STARE BRZMIENIE TEGO PARAGRAFU I ZASTĄPIONO GO NOWYM, PRZYJĘTO TEKST JEDNOLITY UMOWY SPÓŁKI
Activities
Main activity
32.50.ZManufacture of medical and dental instruments and supplies
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. SZELĄGOWSKA, 49, 61-626, POZNAŃ, POLSKA
- Voivodeship
- WIELKOPOLSKIE
- District
- POZNAŃ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-23566-10729-UVVDH-31
- Coordinates
- 52.4079, 16.9335approx.
Risk and payment profile - Clonova
Credibility rating
36.2 / 100
Poor credibility
Insolvency risk
Low
Elevated threat
Closure risk
20
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/13 yrs
Board changes
1
1/13 yrs
PKD changes
2
2/13 yrs
Name changes
0
0/13 yrs
Data from 13 years of registry activity.
Credibility history
Payment reliability score from 2019–2023
Current: E (36/100)
Trend: improving (+3.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2019–2023
Current: 3.1 K PLN
Safe: 617.58 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Clonova
Founded
July 12, 2013
12 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
32.50.Z
Manufacture of medical and dental instruments and supplies
Share capital
5.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
5 years
2019–2023 · profitable: 2/5
Registry entries
25
latest: April 30, 2025
Risk signals
Revenue
235.0 K PLN
2023
Net profit
-18.9 K PLN
2023
Assets
398.1 K PLN
2023
Equity
N/A
2023
EBITDA
N/A
2023
no depreciation data
Valuation
50.9 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Clonova.
No ratings
Related articles
News
Mennica Polska 2026: Q1 revenue +80% YoY (PLN 726.7 m), 838 kg of investment gold (+38%), Bulwary Praskie 95% sold, PLN 1.5 per share dividend
Warsaw-based Mennica Polska S.A. (KRS 0000019196), the only Polish producer of investment-gold bars with three independent business legs (minting, the City Card transit ticket, and the Bulwary Praskie real-estate developer), posted Q1 2026 revenue of PLN 726.7 m (+80% YoY vs PLN 402.9 m) and EBITDA of PLN 56.4 m (+28%). Investment-gold sales: 838 kg (+38% by weight YoY). 2025 closed with EBITDA of around PLN 160 m (+29%) and net profit of around PLN 500 m (a significant part from the developer segment). Bulwary Praskie: 747 apartments with occupancy permits, 95% sold or reserved. Recommended dividend: PLN 1.5 per share (PLN 76.5 m).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
